AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Jan 12, 2022

What will happen on March 25? It’s debatable.

New session tackles controversies in dermatology.


Img 1826

Discourse and lively debate are at the heart of innovative learning and progress. New devices, therapies, socio-economic and political factors as well as new ways of thinking about the dermatology profession produce controversy. The 2022 Debates: Controversies in Dermatology (S017) is a new session at the AAD Annual Meeting 2022 and has been designed for interactive discussion of the issues that dermatologists will be actively encountering this year.

The questions that will be raised for debate run the gamut from clinical to professional and everything in between, including:

  • What are the appropriate indications and use of oral antibiotics for acne, dupilumab for severe atopic dermatitis, PRP for hair loss?
  • What are the risks and benefits of genetic expression profile testing for melanoma and skin cancer screening?
  • What is the impact of current external business and political activism factors on the profession of dermatology?

The roster of expert speakers engaging in the debates include: Neal D. Bhatia, MD, FAAD; Emily Y. Chu, MD, PhD, FAAD; Brett M. Coldiron, MD, FAAD; James Q. Del Rosso, DO, FAAD; Laura K. Ferris, MD, PhD, FAAD; Roy G. Geronemus, MD, FAAD; Lynne J. Goldberg, MD, FAAD; Lawrence J. Green, MD, FAAD; Orit Markowitz, MD, FAAD; Sarah N. Robinson, MD, FAAD; Misha Rosenbach, MD, FAAD; Eric Lawrence Simpson, MD, FAAD; and Jason Bok Lee, MD, FAAD.

You can read the full debate statements and find out who will be addressing which topics by checking out the session online.

The session offers 3.00 CME credit. 

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
DermWorld | Jan: A Juggling Act
Presented by AAD
DermWorld | Jan: A Juggling Act
More in Daily Coverage
Left to right: Taylor Gray, DO, FAAD, and Morgan Brianne Murphrey, MD, MS.
AAD 2023 Annual Meeting
Set yourself up for success
Feb 03, 2023
Img 3020
AAD 2023 Annual Meeting
Management pearls for your practice!
Feb 03, 2023
Getty Images 619236488
AAD 2023 Annual Meeting
These AAD sessions can help you lead the way
Feb 03, 2023
Ben Jacob Friedman, MD, FAAD, and Bridget Shields, MD, FAAD, are leading two, new debate sessions.
AAD 2023 Annual Meeting
We need to talk
Feb 03, 2023
Img 2887
AAD 2023 Annual Meeting
The hottest sessions are back for 2023!
Feb 03, 2023
Img 2929
AAD 2023 Annual Meeting
Exciting industry programs return this year in New Orleans!
Feb 03, 2023
Img 3019
AAD 2023 Annual Meeting
Finish strong. Attend these Tuesday symposiums
Jan 13, 2023
Safi Bahcall, AAD 2023 Annual Meeting Keynote Speaker
AAD 2023 Annual Meeting
Meet keynote speaker Safi Bahcall
Jan 13, 2023
Getty Images 1143723457
AAD 2023 Annual Meeting
Roulez into NOLA for the latest AAD Annual Meeting
Jan 13, 2023
Picture1
AAD 2023 Annual Meeting
Start your session search!
Jan 13, 2023
Venue Photo
AAD 2023 Annual Meeting
Beware of fraudulent meeting registration sites!
Jan 13, 2023
Global Ed Photo
AAD 2023 Annual Meeting
Come a day early for Global Education Day
Jan 13, 2023
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.